View Press Releases
-
PCI WELCOMES JEN DOODY AS HR DIRECTOR
, UK - Jun 2, 2014 - Packaging Coordinators, Inc. (PCI) is pleased to welcome Jen Doody as HR Director for its UK business
Jun 24, 2014
-
TWO ARRAY-INVENTED MEK INHIBITORS SHOWCASED AT ASCO
BOULDER, CO, UNITED STATES - Jun 2, 2014 - Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and selumetinib, were showcased at the 50th annual meeting of the American Society of Clinical Oncology (ASCO)
Jun 2, 2014
-
Gamma Medica's LumaGEM Molecular Breast Imaging Solution Honored as Finalist in the Medical Design Excellence Award - Sunrise Labs, Inc. cited for its role in product development
AUBURN, NH, US - Jun 2, 2014 - Sunrise Labs is pleased to announce that their client, Gamma Medica’s LumaGEM Molecular Breast Imaging (MBI) Solution has been selected as a finalist in the Radiological and Electromechanical Devices Category of the 17th Annual Medical Design Excellence Awards competition
Jun 2, 2014
-
Annual Dotmatics Days in Boston and San Francisco
BISHOP'S STORTFORD, UK - May 29, 2014 - ~~Dotmatics, a leading provider of scientific informatics solutions and services to the pharmaceutical and biotechnology industries, will host the scientific community at Dotmatics Days in the biotech hubs of Boston and San Francisco
May 28, 2014
-
MolecularHealth Signs Internationally-Recognized Oncology Expert to Advisory Board
THE WOODLANDS, TX, UNITED STATES - May 29, 2014 - Today, MolecularHealth announced Waun Ki Hong, M.D., as the newest member of its advisory board. Dr. Hong is one of the nations leading experts on head, neck and lung cancers, recently honored by ASCOs Oncology Luminaries series
May 30, 2014
-
RCRI Appoints Christine Lys as West Coast Senior Business Development Advisor
MINNEAPOLIS, MN - May 29, 2014 - RCRI Appoints Christine Lys as West Coast Senior Business Development AdvisorBefore joining RCRI, Christine Lys, M
May 29, 2014
-
Several Rho Experts to Present at Annual PharmaSUG Conference
CHAPEL HILL, NC, UNITED STATES - May 29, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced its participation at the 2014 Annual Pharmaceutical Industry SAS Users Group (PharmaSUG) Conference June 1-4 in San Diego
May 29, 2014
-
Thomson Reuters Report Identifies BRIC Nations as Emerging Leaders in Global Clinical Trials Landscape
PHILADELPHIA, PA - May 28, 2014 - The Intellectual Property & Science business of Thomson Reuters, the world leader in providing intelligent information to businesses and professionals, today announced the release of Overcoming Clinical Challenges in BRIC Markets, a report exploring the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and China
May 28, 2014
-
ARRAY BIOPHARMA ANNOUNCES DRUG DISCOVERY COLLABORATION AGREEMENT WITH BIOGEN IDEC
BOULDER, CO, UNITED STATES - May 28, 2014 - Array BioPharma (Nasdaq: ARRY) announced today a collaboration agreement with Biogen Idec (NASDAQ: BIIB) for the discovery and development of inhibitors targeting a novel kinase for the treatment of autoimmune disorders
May 28, 2014
-
Rho to Use Clinical Trial Oversight Summit as Platform to Share Best Practices in Clinical Monitoring
CHAPEL HILL, NC, UNITED STATES - May 28, 2014 - Rho to Use Clinical Trial Oversight Summitas Platform to Share Best Practices in Clinical MonitoringClinical trial thought leaders share insight on risk-based monitoring, monitoring with EDC, and the importance of strong relationships between sites and CROs WHAT: Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced its participation at the 5th Annual Clinical Oversight Summit in Boston as a sponsor
May 27, 2014
-
TELCOR Named Microsoft® Partner for 15th Straight Year
LINCOLN, NE - May 28, 2014 - TELCOR Inc announced today it has achieved the prestigious Microsoft Partner status through Microsoft Corp
May 28, 2014
-
Design your target-focused library with OTAVA
TORONTO, КАНАДА - May 28, 2014 - The key goal during drug design process is to limit the number of compounds among large number of available ligands for experimental testing
May 28, 2014
-
Build up your compounds using chemical building blocks from OTAVA!
TORONTO, CANADA - May 26, 2014 - OTAVA specializes in synthesis and distribution of quality chemical building blocks. You could request custom synthesis of chemical compounds of your interest, for this purpose just send single or multiple structures as attached files by filling the form at the OTAVAs web-site (http://www
May 26, 2014
-
Medidata and TransCelerate BioPharma Inc. Announce Joint Initiative
NEW YORK, N.Y. – May 20, 2014 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that it is partnering with TransCelerate BioPharma Inc. ("TransCelerate") on a project designed to inform the nonprofit organization’s continued efforts to modernize and streamline the way clinical trials are conducted and monitored worldwide.
May 20, 2014
-
Rho Expands Team in Research Triangle Park, Continues Hiring
CHAPEL HILL, NC, UNITED STATES - May 20, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, today announced it has added 14 professionals to its Research Triangle Park team in April and has plans to hire an additional 25 more team members as part of its growth expansion strategy in 2014
May 21, 2014
-
ARRAY BIOPHARMA ANNOUNCES KEY ADDITIONS TO SCIENTIFIC LEADERSHIP
BOULDER, PA, UNITED STATES - May 19, 2014 - Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, today announced the appointments of Nicholas A
May 19, 2014
-
ARRAY BIOPHARMA ANNOUNCES CLINICAL DATA PRESENTATIONS AT THE 2014 ASCO ANNUAL MEETING
BOULDER, CO, UNITED STATES - May 14, 2014 - Array BioPharma Inc. (NASDAQ: ARRY) today announced presentations on its MEK inhibitors, binimetinib (MEK162) (co-developing with Novartis) and selumetinib (licensed to AstraZeneca) at the 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held May 30 – June 3, 2014 in Chicago, Illinois
May 14, 2014
-
ARRAY BIOPHARMA PHASE 3 MILO STUDY EVALUATING BINIMETINIB IN OVARIAN CANCER ENROLLING GLOBALLY
BOULDER, CO, UNITED STATES - May 13, 2014 - Array BioPharma Inc. (NASDAQ: ARRY) continues recruitment for its ongoing Phase 3 clinical study in patients with low-grade serous ovarian cancer (LGSOC)
May 14, 2014
-
Dotmatics’ Vortex helps further Chemistry and Biomedical Research in Thailand
BISHOPS STORTFORD, UK - May 12, 2014 - Dotmatics, a leading provider of scientific informatics solutions and services to the academic, pharmaceutical and biotechnology industries, reported today that its premium data analysis and visualisation software, Vortex, is being used by university research groups in Thailand to further their scientific research in diverse fields
May 12, 2014
-
Rho Experts Share 30 Year History of Successful Drug Development Process at 5th Annual OCT East Conference
CHAPEL HILL, NC, UNITED STATES - May 9, 2014 - Rho, a full-service contract research organization (CRO), is showcasing its 30-year history of success in drug development strategies and services at the Outsourcing in Clinical Trials (OCT) East Coast conference May 13-14 in Philadelphia
May 13, 2014